Internal Medicine, Hematology & Oncology · Johnson City, NY
NPI
1447249099
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
30 Harrison St, Suite 100
Johnson City, NY, 13790
Phone (607) 763-6850
Groups this clinician bills Medicare through
Medicare paid, 2024
$65K
869 services
Medicare patients, 2024
405
Average age 74
Drug cost, 2024
$3.9M
1,473 prescriptions
Company payments, 2025
$1,226
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ronald P Harris was code 99214 (office e&m - established), 446 times for 255 patients. In total Ronald P Harris billed 869 services in 17 codes, and Medicare paid $65K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-01-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 446 | 255 | $70.50 | $31K |
| 99213 Office E&M - Established | Facility | 111 | 89 | $43.83 | $4,865 |
| 99233 Hospital E&M - Subsequent | Facility | 87 | 42 | $86.28 | $7,506 |
| 99205 Office E&M - New | Facility | 75 | 75 | $126.37 | $9,478 |
| 99215 Office E&M - Established | Facility | 38 | 36 | $110.76 | $4,209 |
| 99223 Hospital E&M - Initial | Facility | 29 | 28 | $133.13 | $3,861 |
| 99232 Hospital E&M - Subsequent | Facility | 24 | 17 | $48.13 | $1,155 |
| 99222 Hospital E&M - Initial | Facility | 11 | 11 | $91.30 | $1,004 |
By year: 2022 $61K for 884 services; 2023 $63K for 894 services; 2024 $65K for 869 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ronald P Harris prescribed most often to Medicare patients was Letrozole, with 193 prescriptions and refills. In total Ronald P Harris wrote 1,473 Medicare prescriptions that cost $3.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 193 | 486 | 62 | $4,233 |
| Eliquis Apixaban | 76 | 134 | 24 | $76K |
| Anastrozole Generic | 61 | 179 | 21 | $1,338 |
| Prednisone Generic | 60 | 107 | 33 | $484 |
| Ondansetron Hcl Generic | 55 | 55 | 35 | $391 |
| Hydroxyurea Generic | 51 | 117 | 14 | $1,750 |
| Prochlorperazine Maleate Generic | 48 | 48 | 33 | $864 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 39 | 39 | 18 | $1,873 |
| Dexamethasone Generic | 39 | 47 | 16 | $658 |
| Imbruvica Ibrutinib | 38 | 38 | Under 11 | $588K |
| Gabapentin Generic | 37 | 61 | 16 | $504 |
| Acyclovir Generic | 35 | 79 | 11 | $712 |
| Tamoxifen Citrate Generic | 29 | 51 | Under 11 | $552 |
| Abiraterone Acetate Generic | 26 | 26 | Under 11 | $70K |
| Exemestane Generic | 25 | 65 | Under 11 | $2,984 |
Brand drugs: - claims; generic drugs: 1,100 claims; opioid claims: 79.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ronald P Harris $1,226 ($1,226 in general payments such as food, travel and fees) from 25 companies. The largest payer was Novartis Pharmaceuticals Corporation with $256.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 15 | $256 |
| Abbvie Inc. ABBV | 9 | $181 |
| Genentech USA, Inc. ROG.SW | 4 | $73.8 |
| Pfizer Inc. PFE | 4 | $67.26 |
| GlaxoSmithKline, LLC. GSK | 3 | $65.36 |
| Daiichi Sankyo Inc. 4568.T | 3 | $59.56 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $59.47 |
| Lilly USA, LLC LLY | 2 | $47.14 |
| Taiho Oncology, Inc. 4578.T | 1 | $44.42 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $44.36 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.